We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+9.28%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$51.4B
AUM Growth
+$13.1B
Cap. Flow
+$8.75B
Cap. Flow %
17.03%
Top 10 Hldgs %
11.55%
Holding
4,952
New
890
Increased
1,581
Reduced
1,213
Closed
646

Top Sells

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$320M
2
BAC icon
Bank of America
BAC
+$258M
3
KO icon
Coca-Cola
KO
+$215M
4
UNP icon
Union Pacific
UNP
+$215M
5
CSCO icon
Cisco
CSCO
+$214M

Sector Composition

Rank Sector Weight
1 Technology 17.06%
2 Consumer Discretionary 11.45%
3 Healthcare 11.42%
4 Financials 9.96%
5 Industrials 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTAK icon
4251
Catheter Precision
VTAK
$1.05M
0
WATT icon
4252
Energous
WATT
$78.7M
0
XLO icon
4253
Xilio Therapeutics
XLO
$59.8M
0
YJ
4254
Yunji
YJ
$6.16M
$2 ﹤0.01%
1
YQ
4255
17 Education & Technology Group
YQ
$20.8M
$2 ﹤0.01%
1
TRAW icon
4256
Traws Pharma
TRAW
$7.92M
0
TBIO
4257
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
-361
Closed -$4.01K
CNTG
4258
DELISTED
Centogene N.V. Common Shares
CNTG
$2 ﹤0.01%
2
THMO
4259
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
$2 ﹤0.01%
4
TRVN
4260
DELISTED
Trevena, Inc.
TRVN
0
ETAO
4261
DELISTED
Etao International Co., Ltd. Ordinary Shares
ETAO
0
BFX
4262
DELISTED
BowFlex Inc.
BFX
$2 ﹤0.01%
2
NMRD
4263
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$2 ﹤0.01%
8
AMPE
4264
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$2 ﹤0.01%
+1
New +$3
EMKR
4265
DELISTED
Emcore Corp
EMKR
0
RYM
4266
RYTHM Inc
RYM
$41.4M
0
ALGS icon
4267
Aligos Therapeutics
ALGS
$25.2M
0
BNED icon
4268
Barnes & Noble Education
BNED
$445M
0
CADL icon
4269
Candel Therapeutics
CADL
$730M
$1 ﹤0.01%
1
CLNN icon
4270
Clene
CLNN
$69.8M
0
CTSO icon
4271
Cytosorbents Corp
CTSO
$22.6M
$1 ﹤0.01%
1
CURI icon
4272
CuriosityStream
CURI
$145M
$1 ﹤0.01%
2
CYN icon
4273
Cyngn
CYN
$16M
0
GTBP icon
4274
GT Biopharma
GTBP
$12M
0
USBC
4275
USBC Inc
USBC
$123M
0

Similar funds

Qube Research & Technologies (QRT)'s Q4 2023 Portfolio in Review

As of Q4 2023, Qube Research & Technologies (QRT) held 4,952 positions worth $51.4B, up 34% from $38.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Qube Research & Technologies (QRT) deployed $8.75B of net new capital in Q4 2023, opening 890 new positions and adding to 1,581 existing holdings. Its largest new stake was Walt Disney: 2,082,380 shares worth $188M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was McDonald's, an estimated $320M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q4 2023 buy was Walt Disney: 2,082,380 shares worth $188M.
  • Qube Research & Technologies (QRT) added most to UnitedHealth in Q4 2023, an estimated $336M increase.
  • Qube Research & Technologies (QRT)'s biggest Q4 2023 reduction was McDonald's, cutting an estimated $320M.
  • Qube Research & Technologies (QRT) fully exited Activision Blizzard in Q4 2023, selling an estimated $131M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 12% of its $51.4B portfolio in Q4 2023.
  • Qube Research & Technologies (QRT) opened 890 new positions and closed 646 in Q4 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 34% quarter-over-quarter to $51.4B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2023, filed 13 Feb 2024.